These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 8555653

  • 1. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S, Furusawa S, Murata R, Ogata M, Hikichi N, Takayanagi Y, Sasaki K.
    Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
    [Abstract] [Full Text] [Related]

  • 2. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
    Vanhoefer U, Cao S, Minderman H, Toth K, Skenderis BS, Slovak ML, Rustum YM.
    Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155
    [Abstract] [Full Text] [Related]

  • 3. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH, Singh SV.
    Cancer Res; 1992 Dec 01; 52(23):6666-70. PubMed ID: 1423311
    [Abstract] [Full Text] [Related]

  • 4. Combination of cyclosporin A and buthionine sulfoximine (BSO) as a pharmacological strategy for circumvention of multidrug resistance in small cell lung cancer cell lines selected for resistance to doxorubicin.
    Larsson R, Bergh J, Nygren P.
    Anticancer Res; 1991 Dec 01; 11(1):455-9. PubMed ID: 1850223
    [Abstract] [Full Text] [Related]

  • 5. Reversal of doxorubicin resistance in multidrug resistant melanoma cells in vitro and in vivo by dipyridamole.
    Desai PB, Duan J, Sridhar R, Damle BD.
    Methods Find Exp Clin Pharmacol; 1997 May 01; 19(4):231-9. PubMed ID: 9228648
    [Abstract] [Full Text] [Related]

  • 6. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells.
    Dusre L, Mimnaugh EG, Myers CE, Sinha BK.
    Cancer Res; 1989 Feb 01; 49(3):511-5. PubMed ID: 2535960
    [Abstract] [Full Text] [Related]

  • 7. Effect of glutathione depletion by buthionine sulfoximine on doxorubicin toxicity in mice.
    Kisara S, Furusawa S, Takayanagi Y, Sasaki K.
    Res Commun Mol Pathol Pharmacol; 1995 Sep 01; 89(3):401-10. PubMed ID: 8680808
    [Abstract] [Full Text] [Related]

  • 8. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA, Greene K, Ahmad S, Vistica DT.
    Cancer Res; 1987 Mar 15; 47(6):1593-7. PubMed ID: 3815359
    [Abstract] [Full Text] [Related]

  • 9. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH, Gupta V, Singh SV.
    Arch Biochem Biophys; 1994 Jan 15; 308(1):164-70. PubMed ID: 8311448
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
    Chao CC, Huang YT, Ma CM, Chou WY, Lin-Chao S.
    Mol Pharmacol; 1992 Jan 15; 41(1):69-75. PubMed ID: 1346333
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of buthionine sulfoximine-enhanced doxorubicin toxicity in metallothionein overexpressing transgenic mouse heart.
    Wu HY, Kang YJ.
    J Pharmacol Exp Ther; 1998 Nov 15; 287(2):515-20. PubMed ID: 9808675
    [Abstract] [Full Text] [Related]

  • 12. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
    Kang YJ.
    Cell Mol Biol Res; 1995 Nov 15; 41(2):131-6. PubMed ID: 8581064
    [Abstract] [Full Text] [Related]

  • 13. Lack of enhanced antitumor efficacy for L-buthionine sulfoximine in combination with carmustine, cyclophosphamide, doxorubicin or melphalan in mice.
    Soble MJ, Dorr RT.
    Anticancer Res; 1988 Nov 15; 8(1):17-22. PubMed ID: 3358633
    [Abstract] [Full Text] [Related]

  • 14. Effect of buthionine sulfoximine on toxicity of verapamil and doxorubicin to multidrug resistant cells and to mice.
    Ford JM, Yang JM, Hait WN.
    Cancer Res; 1991 Jan 01; 51(1):67-72. PubMed ID: 1988108
    [Abstract] [Full Text] [Related]

  • 15. Reduction of doxorubicin resistance by tetrandrine and dauricine in harringtonine-resistant human leukemia (HL60) cells.
    He QY, Meng FH, Zhang HQ.
    Zhongguo Yao Li Xue Bao; 1996 Mar 01; 17(2):179-81. PubMed ID: 9772674
    [Abstract] [Full Text] [Related]

  • 16. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
    Chen G, Waxman DJ.
    J Pharmacol Exp Ther; 1995 Sep 01; 274(3):1271-7. PubMed ID: 7562498
    [Abstract] [Full Text] [Related]

  • 17. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May 01; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 18. Effect of doxorubicin on glutathione and glutathione-dependent enzymes in cultured rat heart cells.
    Paranka NS, Dorr RT.
    Anticancer Res; 1994 May 01; 14(5A):2047-52. PubMed ID: 7847848
    [Abstract] [Full Text] [Related]

  • 19. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Majumder S, Dutta P, Mookerjee A, Choudhuri SK.
    Chem Biol Interact; 2006 Feb 01; 159(2):90-103. PubMed ID: 16289015
    [Abstract] [Full Text] [Related]

  • 20. The ability of selected pyridinium salts to increase the cytotoxic activity of vincristine but not doxorubicin towards sensitive and multidrug resistant promyelocytic leukaemia HL60 cells.
    Maruszewska A, Kostrzewa-Nowak D, Adamus J, Czupryńska K, Maryniak D, Gebicki J, Tarasiuk J.
    J Pharm Pharmacol; 2008 May 01; 60(5):647-53. PubMed ID: 18416942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.